Brenus Pharma
Created in 2019
- BETA
Trend leader (A+)
Existing signals make this entity one of the most dynamic startups Social networks
26 3,744Activities
Technologies
Entity types
Location
Lyon, France
Lyon
France
Employees
Scale: 11-50
Estimated: 18
SIREN
802549030Engaged corporates
26
9 13Added in Motherbase
1Â year, 9Â months ago
biotech Value proposition
Next-generation cancer treatment bringing the immune system one step ahead of cancer 🧬🟣
Brenus Pharma is a pioneering clinical stage biotech aiming to prevent cancer recurrence, the main challenge for solid tumors - causing 10M deaths each year worldwide.
We developped a next-generation cancer treatment, thanks to our “off-the-shelf” therapeutic platform.
Our lead candidate is a proteomic-driven immunotherapy targetting colorectal cancer (CRC), the 2nd deadliest cancer worldwide.
- Our allogeneic platform generates therapeutics that efficiently educate the immune system, with more potent, diverse and novel targets than any existing therapies. (Characterized by advanced multiomics technologies)
- We overcome limitations of several technologies such as mRNA vaccines thanks to our enhanced immunogenicity and standardized GMP manufacturing: we keep control of costs and supply.
Awarded “Best Biotech Startup” in 2024 in France, we recently closed a $25M SERIES A to accelerate our clinical development.
We are currently envisaging clinical collaborations.
Brenus Pharma sets a new paradigm in oncology, by giving back to patients the ability to fight against their disease.
oncology, cancer, immune-therapy, innovation, cell therapy, healthtech, biotech, and cancervaccineOriginal language
Next-generation cancer treatment bringing the immune system one step ahead of cancer 🧬🟣
Brenus Pharma is a pioneering clinical stage biotech aiming to prevent cancer recurrence, the main challenge for solid tumors - causing 10M deaths each year worldwide.
We developped a next-generation cancer treatment, thanks to our “off-the-shelf” therapeutic platform.
Our lead candidate is a proteomic-driven immunotherapy targetting colorectal cancer (CRC), the 2nd deadliest cancer worldwide.
- Our allogeneic platform generates therapeutics that efficiently educate the immune system, with more potent, diverse and novel targets than any existing therapies. (Characterized by advanced multiomics technologies)
- We overcome limitations of several technologies such as mRNA vaccines thanks to our enhanced immunogenicity and standardized GMP manufacturing: we keep control of costs and supply.
Awarded “Best Biotech Startup” in 2024 in France, we recently closed a $25M SERIES A to accelerate our clinical development.
We are currently envisaging clinical collaborations.
Brenus Pharma sets a new paradigm in oncology, by giving back to patients the ability to fight against their disease.
Brenus Pharma
https://brenus-pharma.com/
| Corporate | Type | Tweets | Articles | |
|---|---|---|---|---|
 PMT Public business cluster, French Cluster, Civic and Social Organizations | PMT Public business cluster, French Cluster, Civic and Social Organizations | Other 2 Apr 2024 | | |
 Medicen Paris Region Public business cluster, French Cluster, Civic and Social Organizations | Medicen Paris Region Public business cluster, French Cluster, Civic and Social Organizations | Other 18 Jun 2024 | | |
 Agence Economique Régionale Bourgogne-Franche-Comté - AER BFC / AERBFC Government Administration | Agence Economique Régionale Bourgogne-Franche-Comté - AER BFC / AERBFC Government Administration | Other 22 Mar 2024 | | |
 | Agence régionale de santé (ARS) Auvergne-Rhône-Alpes | Other 3 Mar 2024 | | |
 | Ministère de la Santé | Other 3 Mar 2024 | | |
 Assurance Maladie Insurance, Government Administration | Assurance Maladie Insurance, Government Administration | Other 3 Mar 2024 | | |
 CCI GRAND EST Chamber of commerce, Government Administration | CCI GRAND EST Chamber of commerce, Government Administration | Other 14 Nov 2023 | | |
 Paris Biotech Santé Startup accelerator & VC, Civic and Social Organizations | Paris Biotech Santé Startup accelerator & VC, Civic and Social Organizations | Other 14 Nov 2023 | | |
 Business France National and local authorities, Government Administration | Business France National and local authorities, Government Administration | Other 20 Sep 2024 | | |
 Oxford Science Enterprises Startup accelerator & VC, Venture Capital and Private Equity Principals | Oxford Science Enterprises Startup accelerator & VC, Venture Capital and Private Equity Principals | Other 31 Jul 2023 | | |